Wound Care Biologics Market Research Report – Forecast to 2027

Wound Care Biologics Market Research Report: Information by Product Type (Biological Skin Substitutes, Topical Agents), Wound Type (Surgical and Traumatic Wounds, Diabetic Foot Ulcer, Pressure Ulcers), End User (Hospitals, Clinics) -Forecast till 2027

ID: MRFR/MED/5101-HCR | February 2021 | Region: Global | 100 pages

Wound Care Biologics Market Scenario


The wound care biologics market is expected to grow significantly over the forecast period. It is anticipated that the wound care biologics market held a market value of USD 1.20 billion in 2017 and wound care biologics market is projected to grow at a CAGR of 9.9% over the forecast period. Wound care biologics products create an active healing environment which allows the body to heal wound naturally. The wound care biologics are mainly used to the management of diabetic ulcers, venous ulcers, arterial ulcers, and pressure ulcers.


The factors such as the increasing prevalence of chronic diseases and burn injuries, and increasing healthcare expenditure are expected to propel the growth of the wound care biologics market. According to the Centers for Disease Control and Prevention (CDC), in 2015, about 2.8 million people were hospitalized due to injuries. However, the high cost of treatment, lack of awareness, and poor education and training hamper the wound care biologics market growth over the forecast period.


Segmentation


The wound care biologics market has been segmented into product type, wound type, and end user.


Based on product type, has been segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is expected to account for the largest share and fastest growing segment of the market in 2017.


The market, by wound type, has been segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.


The market, by end user, has been segmented into hospitals, ambulatory surgical centers, and clinics.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wound care biologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European wound care biologics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The wound care biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wound care biologics market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


Integra LifeSciences Corporation (US), Smith & Nephew (UK), Wright Medical (US), Mölnlycke Health Care AB (Sweden), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Marine Polymer Technologies, Inc. (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), and Organogenesis (US) are some of the key players in the wound care biologics market.


Regional Market Summary


Geographically, the Americas is anticipated to dominate the wound care biologics market owing to a well-developed healthcare sector, growing occurrences of chronic wounds, rising prevalence of diabetes and rising geriatric population. According to the National Diabetes Statistics Report 2017, about 30.3 million suffer from diabetes in Americans.


Europe is expected to hold the second largest position in the wound care biologics market. The market growth in this region is attributed to the increasing prevalence of diabetes and developed healthcare infrastructure.


The wound care biologics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the huge patient population of chronic diseases such as diabetes in countries such as India and China.


The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.


Wound Care Biologics Market, by Product Type



  • Skin Substitute

  • Human Donor Tissue

  • Acellular animal-derived

  • Biosynthetic

  • Topical Agents


Wound Care Biologics Market, by Wound Type



  • Ulcers

  • Diabetic foot ulcers

  • Venous ulcers

  • Pressure ulcers

  • Other ulcers

  • Surgical and Traumatic Wounds

  • Burns


Wound Care Biologics Market, by End User



  • Hospitals

  • Clinics

  • Other End Users


Wound Care Biologics Market, by Region



  • Americas





    • North America

    • US

    • Canada

    • South America





  • Europe





    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe





  • Asia-Pacific





    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • The Middle East & Africa





    • Middle East

    • Africa




Intended Audience



  • Wound Care Biologics Manufacturers and Vendors

  • Various Research and Consulting Firms

  • Wound Care Biologics Distributors

  • Hospitals



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 1.20 Billion
  • 2027: Significant Value
  •   CAGR   9.9% (2018-2023)
      Base Year   2019
      Forecast Period   2018-2027
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product Type, Wound Type, and End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Integra LifeSciences Corporation (US), Smith & Nephew (UK), Wright Medical (US), Mölnlycke Health Care AB (Sweden), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Marine Polymer Technologies, Inc. (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), and Organogenesis (US)
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Increasing prevalence of chronic diseases and burn injuries
  • Increasing healthcare expenditure


  • Speak to Analyst Ask for Customization

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Wound Care Biologics Market, by Product Type

    6.1 Introduction

    6.2 Skin Substitute

    6.2.1 Human Donor Tissue

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.2 Acellular Animal-derived

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.3 Biosynthetic

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Topical Agents

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Wound Care Biologics Market, by Wound Type

    7.1 Introduction

    7.2 Ulcers

    7.3.1 Diabetic Foot Ulcers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3.2 Venous Ulcers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3.3 Pressure Ulcers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3.4 Other Ulcers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Surgical and Traumatic Wounds

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Burns

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Wound Care Biologics Market, by End User

    8.1 Introduction

    8.2 Hospitals

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Other End Users

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Wound Care Biologics Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 South Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 Middle East

    9.5.2 Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies


    Chapter 11. Company Profiles

    11.1 Integra LifeSciences Corporation

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials Overview

    11.1.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Smith & Nephew

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Wright Medical

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Mölnlycke Health Care AB

    11.4.1 Company Overview

    11.4.2 Product Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 MiMedx Group

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Vericel Corporation

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 Anika Therapeutics

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financial Overview

    11.7.4 Key Developments

    11.7.5 SWOT Analysis


    11.8 Osiris Therapeutics

    11.8.1 Overview

    11.8.2 Product Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Organogenesis

    11.9.1 Overview

    11.9.2 Product Overview

    11.9.3 Financials

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Solsys Medical

    11.10.1 Overview

    11.10.2 Product Overview

    11.10.3 Financials

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s Viewpoint

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Predictions for the Wound Care Biologics Industry

    Chapter 13. Appendix

    LIST OF TABLES

    Table 1 Global Wound Care Biologics Market Synopsis, 2020-2027

    Table 2 Global Wound Care Biologics Market Estimates and Forecast, 2020-2027

    (USD Million)

    Table 3 Global Wound Care Biologics Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Wound Care Biologics Market, by Product Type, 2020-2027 (USD Million)

    Table 5 Global Wound Care Biologics Market, by Wound Type, 2020-2027 (USD

    Million)

    Table 7 Global Wound Care Biologics Market, by End User, 2020-2027 (USD

    Million)

    Table 8 North America: Wound Care Biologics Market, by Product Type, 2020-2027

    (USD Million)

    Table 9 North America: Wound Care Biologics Market, by Wound Type, 2020-2027

    (USD Million)

    Table 10 North America: Wound Care Biologics Market, by End User, 2020-2027

    (USD Million)

    Table 11 US: Wound Care Biologics Market, by Product Type, 2020-2027

    (USD Million)

    Table 12 US: Wound Care Biologics Market, by Wound Type, 2020-2027

    (USD Million)

    Table 13 US: Wound Care Biologics Market, by End User, 2020-2027 (USD Million)

    Table 14 Canada: Wound Care Biologics Market, by Product Type, 2020-2027 (USD

    Million)

    Table 15 Canada: Wound Care Biologics Market, by Wound Type, 2020-2027 (USD

    Million)

    Table 16 Canada: Wound Care Biologics Market, by End User, 2020-2027 (USD

    Million)

    Table 17 South America: Wound Care Biologics Market, by Product Type, 2020-2027

    (USD Million)

    Table 18 South America: Wound Care Biologics Market, by Wound Type, 2020-2027

    (USD Million)

    Table 19 South America: Wound Care Biologics Market, by End User, 2020-2027

    (USD Million)

    Table 20 Europe: Wound Care Biologics Market, by Product Type, 2020-2027 (USD

    Million)

    Table 21 Europe: Wound Care Biologics Market, by Wound Type, 2020-2027 (USD

    Million)

    Table 22 Europe: Wound Care Biologics Market, by End User, 2020-2027 (USD

    Million)

    Table 23 Western Europe: Wound Care Biologics Market, by Product Type, 2020-2027 (USD Million)

    Table 24 Western Europe: Wound Care Biologics Market, by Wound Type, 2020-2027 (USD Million)

    Table 25 Western Europe: Wound Care Biologics Market, by End User, 2020-2027

    (USD Million)

    Table 26 Eastern Europe: Wound Care Biologics Market, by Product Type, 2020-2027 (USD Million)

    Table 27 Eastern Europe: Wound Care Biologics Market, by Wound Type, 2020-2027

    (USD Million)

    Table 28 Eastern Europe: Wound Care Biologics Market, by End User, 2020-2027

    (USD Million)

    Table 29 Asia-Pacific: Wound Care Biologics Market, by Product Type, 2020-2027

    (USD Million)

    Table 30 Asia-Pacific: Wound Care Biologics Market, by Wound Type, 2020-2027

    (USD Million)

    Table 31 Asia-Pacific: Wound Care Biologics Market, by End User, 2020-2027 (USD

    Million)

    Table 32 Middle East & Africa: Wound Care Biologics Market, by Product Type,

    2020-2027 (USD Million)

    Table 33 Middle East & Africa: Wound Care Biologics Market, by Wound Type, 2020-2027 (USD Million)

    Table 34 Middle East & Africa: Wound Care Biologics Market, by End User, 2020-2027 (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Wound Care Biologics Market

    Figure 3 Segmentation Market Dynamics for Global Wound Care Biologics Market

    Figure 4 Global Wound Care Biologics Market Share, by Product Type, 2020

    Figure 5 Global Wound Care Biologics Market Share, by Wound Type, 2020

    Figure 6 Global Wound Care Biologics Market Share, by End User, 2020

    Figure 7 Global Wound Care Biologics Market Share, by Region, 2020

    Figure 8 North America: Wound Care Biologics Market Share, by Country, 2020

    Figure 9 Europe: Wound Care Biologics Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Wound Care Biologics Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Wound Care Biologics Market Share, by Country, 201

    Figure 12 Global Wound Care Biologics Market: Company Share Analysis, 2020 (%)

    Figure 13 Integra LifeSciences Corporation: Key Financials

    Figure 14 Integra LifeSciences Corporation: Segmental Revenue

    Figure 15 Integra LifeSciences Corporation: Geographical Revenue

    Figure 16 Smith & Nephew: Key Financials

    Figure 17 Smith & Nephew: Segmental Revenue

    Figure 18 Smith & Nephew: Geographical Revenue

    Figure 19 Wright Medical: Key Financials

    Figure 20 Wright Medical: Segmental Revenue

    Figure 21 Wright Medical: Geographical Revenue

    Figure 22 Mölnlycke Health Care AB: Key Financials

    Figure 23 Mölnlycke Health Care AB: Segmental Revenue

    Figure 24 Mölnlycke Health Care AB: Geographical Revenue

    Figure 25 MiMedx Group: Key Financials

    Figure 26 MiMedx Group: Segmental Revenue

    Figure 27 MiMedx Group. Geographical Revenue

    Figure 28 Vericel Corporation: Key Financials

    Figure 29 Vericel Corporation: Segmental Revenue

    Figure 30 Vericel Corporation: Geographical Revenue

    Figure 31 Anika Therapeutics: Key Financials

    Figure 32 Anika Therapeutics: Segmental Revenue

    Figure 33 Anika Therapeutics: Geographical Revenue

    Figure 34 Osiris Therapeutics: Key Financials

    Figure 35 Osiris Therapeutics: Segmental Revenue

    Figure 36 Osiris Therapeutics: Geographical Revenue

    Figure 37 Organogenesis: Key Financials

    Figure 38 Organogenesis: Segmental Revenue

    Figure 39 Organogenesis: Geographical Revenue

    Figure 40 Solsys Medical : Key Financials

    Figure 41 Solsys Medical: Segmental Revenue

    Figure 42 Solsys Medical: Geographical Revenue

    Figure 43 ACell : Key Financials

    Figure 44 ACell : Segmental Revenue

    Figure 45 ACell : Geographical Revenue

    Figure 46 Kerecis : Key Financials

    Figure 47 Kerecis : Segmental Revenue

    Figure 48 Kerecis : Geographical Revenue